Improving the diagnosis of Lyme disease: See who you could be missing with ZEUS Borrelia MTTT

Improving the diagnosis of Lyme disease with ZEUS Borrelia MTTT. See who you could be missing.

A review and discussion of the enhanced sensitivity of the ZEUS Borrelia Modified Two-Tiered Testing (MTTT) algorithm in detecting early Lyme disease as compared to the Standard Two-Tiered Testing (STTT) algorithm. If you are still using STTT learn how you can start detecting nearly double the number of early cases (stage 1 & 2) of Lyme disease with ZEUS MTTT and eliminate the need for immunoblots.

Presented by

Ron CRUVER

Business Line Manager-Vector Borne Diseases

Sebia Autoimmune & Infectious Diseases

Biography

Ron Cruver manages ZEUS’s Vector-Borne Disease Business Line and joined the company in 2020. Ron brings over 30 years of industry experience working with in vitro diagnostic medical devices. He specializes in infectious disease serology testing with an emphasis Lyme disease testing. Ron has a bachelor’s degree in Recombinant Gene Technology from the State University of New York at Fredonia.